TY - JOUR AU - Raju, Ravikiran AU - Raju, Sagar AU - Zhao, Yanlin AU - Rubin, Eric T1 - Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease T2 - Emerging Infectious Disease journal PY - 2016 VL - 22 IS - 3 SP - 365 SN - 1080-6059 AB - The nontuberculous mycobacteria (NTM), defined as any mycobacterial pathogen other than Mycobacterium tuberculosis or Mycobacterium leprae, are a diverse group of pathogens that collectively cause a substantive but often unappreciated worldwide burden of illness. Although NTMs may cause illness similar to M. tuberculosis, these pathogens generally do not respond to classic tuberculosis (TB) drug regimens, resulting in misdiagnosis and poor treatment, particularly in resource-poor settings. Although a few high-quality epidemiologic surveys have been made on the topic, existing evidence suggests that NTM-associated disease is much more common than previously thought: more common than TB in the industrialized world and likely increasing in prevalence globally. Despite this evidence, these organisms remain markedly understudied, and few international grants support basic science and clinical research. Here we suggest that the considerable efforts in developing new treatments and diagnostics for TB can be harnessed in the fight against NTM-associated illnesses. KW - bacteria KW - respiratory infections KW - tuberculosis KW - nontuberculous mycobacteria KW - Mycobacterium tuberculosis KW - Mtb KW - Mycobacterium leprae KW - NTM disease KW - M. abscessus KW - M. avium KW - M. ulcerans KW - antitubercular KW - antimycobacterial KW - macrolides KW - clarithromycin KW - oxazolidinones KW - bedaquiline KW - delamanid KW - HIV DO - 10.3201/eid2203.151643 UR - https://wwwnc.cdc.gov/eid/article/22/3/15-1643_article ER - End of Reference